Literature DB >> 4640564

Duration of anticoagulant therapy in venous thrombo--embolism.

E F O'Sullivan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4640564     DOI： 10.5694/j.1326-5377.1972.tb103752.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  9 in total

Review 1.  Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.

Authors:  Cristina Tarango; Sam Schulman; Marisol Betensky; Neil A Goldenberg
Journal:  Expert Rev Hematol       Date:  2017-12-17       Impact factor: 2.929

2.  Diagnosis and treatment of venous thromboembolism by consultants in Scotland.

Authors:  A G Prentice; G D Lowe; C D Forbes
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

Review 3.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

4.  Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.

Authors:  I A Campbell; D P Bentley; R J Prescott; P A Routledge; H G M Shetty; I J Williamson
Journal:  BMJ       Date:  2007-02-08

Review 5.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 6.  Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy.

Authors:  H G Shetty; A G Fennerty; P A Routledge
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

7.  Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.

Authors:  Florent Boutitie; Laurent Pinede; Sam Schulman; Giancarlo Agnelli; Gary Raskob; Jim Julian; Jack Hirsh; Clive Kearon
Journal:  BMJ       Date:  2011-05-24

8.  Tenecteplase compared with streptokinase and heparin in the treatment of pulmonary embolism: an observational study.

Authors:  Ashish Agrawal; Shibnath Kamila; Aditya Donepudi; Rajendra Premchand
Journal:  J Drug Assess       Date:  2017-01-03

Review 9.  Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

Authors:  Saskia Middeldorp; Martin H Prins; Barbara A Hutten
Journal:  Cochrane Database Syst Rev       Date:  2014-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.